Tissue-resident CD8 + T cells drive compartmentalized and chronic autoimmune damage against CNS neurons
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
The mechanisms underlying the chronicity of autoimmune diseases of the central nervous system (CNS) are largely unknown. In particular, it is unclear whether tissue-resident memory T cells (TRM) contribute to lesion pathogenesis during chronic CNS autoimmunity. Here, we observed that a high frequency of brain-infiltrating CD8+ T cells exhibit a TRM-like phenotype in human autoimmune encephalitis. Using mouse models of neuronal autoimmunity and a combination of T single-cell transcriptomics, high-dimensional flow cytometry, and histopathology, we found that pathogenic CD8+ T cells behind the blood-brain barrier adopt a characteristic TRM differentiation program, and we revealed their phenotypic and functional heterogeneity. In the diseased CNS, autoreactive tissue-resident CD8+ T cells sustained focal neuroinflammation and progressive loss of neurons, independently of recirculating CD8+ T cells. Consistently, a large fraction of autoreactive tissue-resident CD8+ T cells exhibited proliferative potential as well as proinflammatory and cytotoxic properties. Persistence of tissue-resident CD8+ T cells in the CNS and their functional output, but not their initial differentiation, were crucially dependent on CD4+ T cells. Collectively, our results point to tissue-resident CD8+ T cells as essential drivers of chronic CNS autoimmunity and suggest that therapies targeting this compartmentalized autoreactive T cell subset might be effective for treating CNS autoimmune diseases. Descrip…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Animal and in-vitro studies demonstrate that inflammatory stimuli may initiate long-term priming of the microglia, peripheral CD4+ and CD8+ T cells to a proinflammatory state, (352-354) potentially increasing amyloid plaque deposition.(355)”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [353]
Citations
Cites
Fast gene set enrichment analysis
Korotkevich, G., Sukhov, V., Budin, N., Shpak, B., Artyomov, M. N., & Sergushichev, A. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/060012 · Cited by 3,454
Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis
Levine, J. H., Simonds, E. F., Bendall, S. C., Davis, K. L., Amir, E.-A. D., Tadmor, M. D., Litvin, O., Fienberg, H. G., Jager, A., Zunder, E. R., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.047 · Cited by 2,303 · cited 2×
“Supplementary Materials Figures S1 – S8 Tables S1 – S3 Datafile S1 References (45-49)”
BackgroundAntibody-Mediated Encephalitis
Dalmau, J., & Graus, F. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1708712 · Cited by 1,329 · cited 1×
“INTRODUCTION Chronic autoimmune diseases of the central nervous system (CNS) can target different CNS-resident cell types, including oligodendrocytes as suspected in multiple sclerosis (MS) (1, 2), astrocytes as identified in neuromyelitis optica spectrum disorder (3), or neurons in conditions such as autoimmune encep…”
BackgroundMultiple Sclerosis: Mechanisms and Immunotherapy
Baecher-Allan, C., Kaskow, B. J., & Weiner, H. L. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.021 · Cited by 938
TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection
Alfei, F., Kanev, K., Hofmann, M., Wu, M., Ghoneim, H. E., Roelli, P., Utzschneider, D. T., von Hoesslin, M., Cullen, J. G., Fan, Y., et al. (2019) · Nature · doi:10.1038/s41586-019-1326-9 · Cited by 899
Self-citationThe movers and shapers in immune privilege of the CNS
Engelhardt, B., Vajkoczy, P., & Weller, R. O. (2017) · Nature Immunology · doi:10.1038/ni.3666 · Cited by 893 · cited 1×
“The concept of the immune privilege of the CNS has been challenged by the identification of several gateways between the peripheral immune system and the brain, despite the restrictive blood-brain barrier (34, 35).”
BackgroundT cells from patients with Parkinson’s disease recognize α-synuclein peptides
Sulzer, D., Alcalay, R. N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W. H., Mao, X., et al. (2017) · Nature · doi:10.1038/nature22815 · Cited by 866 · cited 1×
“An autoimmune process also appears at play in prevalent neurodegenerative disorders such as Parkinson’s disease (6).”
BackgroundAnalysis of islet inflammation in human type 1 diabetes
Willcox, A., Richardson, S. J., Bone, A. J., Foulis, A. K., & Morgan, N. G. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03860.x · Cited by 712 · cited 1×
“There is evidence that antigenic persistence is a key parameter for chronic inflammation and complete destruction of the cellular targets often results in subsiding of local inflammation (5, 7, 8).”
BackgroundImmunopathology of autoantibody-associated encephalitides: clues for pathogenesis
Bien, C. G., Vincent, A., Barnett, M. H., Becker, A. J., Blumcke, I., Graus, F., Jellinger, K. A., Reuss, D. E., Ribalta, T., Schlegel, J., et al. (2012) · Brain · doi:10.1093/brain/aws082 · Cited by 695
Self-citationTissue-Resident T Cells and Other Resident Leukocytes
Masopust, D., & Soerens, A. G. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053214 · Cited by 608
Cited by
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01296-0 · Cited by 3,860
Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting
Charabati, M., Wheeler, M. A., Weiner, H. L., & Quintana, F. J. (2023) · Cell · doi:10.1016/j.cell.2023.03.008 · Cited by 222
The Tryptophan and Kynurenine Pathway Involved in the Development of Immune-Related Diseases
Tsuji, A., Ikeda, Y., Yoshikawa, S., Taniguchi, K., Sawamura, H., Morikawa, S., Nakashima, M., Asai, T. T., & Matsuda, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065742 · Cited by 178
“Furthermore, the AHR could modify the differentiation and function of both CD4+ T cells and CD8+ T cells [97], which might be involved in chronic autoimmune damage to CNS neurons [98] (Figure 2).”
BackgroundThe Multifaceted Role of Tissue-Resident Memory T Cells
Christo, S. N., Park, S. L., Mueller, S. N., & Mackay, L. K. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101320-020220 · Cited by 154
Tröscher, A. R., Mair, K. M., de Juan, L. V., Köck, U., Steinmaurer, A., Baier, H., Becker, A. J., Blümcke, I., Finzel, M., Geis, C., et al. (2022) · Brain · doi:10.1093/brain/awac404 · Cited by 96
“This was also demonstrated recently in a CD8-mediated translational model for paraneoplastic encephalitis.(56) Second, PD-1 is involved in negative regulation of autoimmune reactions.”
BackgroundSelf-citationOstkamp, P., Deffner, M., Schulte-Mecklenbeck, A., Wünsch, C., Lu, I.-N., Wu, G. F., Goelz, S., De Jager, P. L., Kuhlmann, T., Gross, C. C., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.adc9778 · Cited by 91
The immunopathogenesis of narcolepsy type 1
Liblau, R. S., Latorre, D., Kornum, B. R., Dauvilliers, Y., & Mignot, E. J. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-023-00902-9 · Cited by 91
“Interestingly, in both the adoptive transfer model and the vaccine model, the ‘autoreactive’ CD8 + T cells in the hypothalamus adopted a tissue-resident memory T cell signature 83 .”
Self-citationSphingosine 1-phosphate receptor, a new therapeutic direction in different diseases
Chen, H., Wang, J., Zhang, C., Ding, P., Shuxia, T., Chen, J., Ji, G., & Wu, T. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113341 · Cited by 96
Tissue-resident immune cells: from defining characteristics to roles in diseases
Li, J., Chu, X., Li, C., & He, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02050-5 · Cited by 102
Lee, H., Guo, Y., Ross, J., Schoen, S. J., Degertekin, F. L., & Arvanitis, C. (2022) · Science Advances · doi:10.1126/sciadv.add2288 · Cited by 75
Vincenti, I., Page, N., Steinbach, K., Yermanos, A., Lemeille, S., Nunez, N., Kreutzfeldt, M., Klimek, B., Di Liberto, G., Egervari, K., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl6058 · Cited by 70
“However, it can be assumed that antigen presentation and reactivation of TRM are not limited to astrocytes but can also be mediated by other cells resident in the CNS including oligodendrocytes, microglial cells, or, as described in the companion article, neurons (76).”
BackgroundSelf-citationImmune mechanisms and shared immune targets in neurodegenerative diseases
Weiner, H. L. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01046-7 · Cited by 74
Ayasoufi, K., Wolf, D. M., Namen, S. L., Jin, F., Tritz, Z. P., Pfaller, C. K., Zheng, J., Goddery, E. N., Fain, C. E., Gulbicki, L. R., et al. (2022) · SSRN Electronic Journal · doi:10.1016/j.bbi.2023.05.009 · Cited by 61
Targeting cytokine networks in neuroinflammatory diseases
Becher, B., Derfuss, T. J., & Liblau, R. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01026-y · Cited by 60
Self-citationGuo, Y., Chen, J., Ji, W., Xu, L., Xie, Y., He, S., Lai, C., Hou, K., Li, Z., Chen, G., et al. (2023) · Molecular Therapy Methods & Clinical Development · doi:10.1016/j.omtm.2023.08.021 · Cited by 47
Rossi, S., Farina, A., Malvaso, A., Dinoto, A., Fionda, L., Cornacchini, S., Florean, I., Zuliani, L., Garibaldi, M., Lauletta, A., et al. (2024) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200314 · Cited by 39
“…as recently suggested by the detection of long-lived tissue-resident memory T cells in the autoptic lesions of patients with ICI-na¨ ı ve PNS. 28 In this regard, the mechanisms underlying chronic active and inactive n-irAEs are likely to represent opposite ends along a continuum of in fl…”
BackgroundKimura, K., Nishigori, R., Hamatani, M., Sawamura, M., Ashida, S., Fujii, C., Takata, M., Lin, Y., Sato, W., Okamoto, T., et al. (2023) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200172 · Cited by 42
Feng, R., Spieth, L., Liu, L., Berghoff, S. A., Franz, J., Liu, Q., Wang, Z., Tiwari, V., Vitale, S., Frerich, S., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.10.003 · Cited by 48
“Supporting recent findings, 30,31 we found several transcripts enriched in tissue-resident memory subsets (e.g., CD69 , ITGA1 , and TOX ) among the T cell marker genes (Table S5).”
CD8+ T cells recognizing a neuron-restricted antigen injure axons in a model of multiple sclerosis
Clarkson, B. D. S., Grund, E. M., Standiford, M. M., Mirchia, K., Westphal, M. S., Muschler, L. S., & Howe, C. L. (2023) · Journal of Clinical Investigation · doi:10.1172/jci162788 · Cited by 36
“In these studies, resting memory CD8 + T cells targeting HA in orexigenic neurons accumulated in the hypothalamus and contributed to injury (51, 52).”
BackgroundMerkler, D., Vincenti, I., Masson, F., & Liblau, R. S. (2022) · Current Opinion in Immunology · doi:10.1016/j.coi.2022.102211 · Cited by 30
Self-citationHsiao, C., Engelenburg, H. J., Jongejan, A., Zhu, J. K., Zhang, B., Mingueneau, M., Moerland, P. D., Huitinga, I., Smolders, J., & Hamann, J. (2022) · iScience · doi:10.1016/j.isci.2022.105785 · Cited by 33
Serafini, B., Rosicarelli, B., Veroni, C., & Aloisi, F. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578036 · Cited by 30
The role of the adaptive immune system in the initiation and persistence of multiple sclerosis
Afzali, A. M., & Korn, T. (2025) · Seminars in Immunology · doi:10.1016/j.smim.2025.101947 · Cited by 25
Pignata, A., Frieser, D., Gonzalez-Fierro, C., Hsiao, C., Engelenburg, H. J., Alis, M., Fijalkow, I., Cazaentre, V., Nozeran, L., Miranda-Capet, R., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adp8109 · Cited by 32
Self-citationNakajima, A., Yanagimura, F., Saji, E., Shimizu, H., Toyoshima, Y., Yanagawa, K., Arakawa, M., Hokari, M., Yokoseki, A., Wakasugi, T., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02725-x · Cited by 29
“…CD69 + B-cell lymphoma protein 2-positive (BCL2 + ) T RM cells or CD103 + CD8 + T RM cells accumulate in lesions in patients with multiphasic or chronic active diseases including NMOSD [79], acute active/chronic active/ progressive MS [3, 19, 50, 79] and paraneoplastic neurological syndrome [20].”
The role of kynurenines in migraine-related neuroimmune pathways
Körtési, T., Nagy-Grócz, G., & Vécsei, L. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01833-z · Cited by 27
Keeping T cell memories in mind
Mix, M. R., & Harty, J. T. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.10.001 · Cited by 24
Gonzalez-Fierro, C., Fonte, C., Dufourd, E., Cazaentre, V., Aydin, S., Engelhardt, B., Caspi, R. R., Xu, B., Martin‐Blondel, G., Spicer, J. A., et al. (2023) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200117 · Cited by 24
Self-citationPorte, R., Belloy, M., Audibert, A., Bassot, E., Aïda, A., Alis, M., Miranda-Capet, R., Jourdes, A., van Gisbergen, K. P. J. M., Masson, F., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2403054121 · Cited by 28
Self-citationActivated αβ T and reduced mucosa-associated invariant T cells in LGI1- and CASPR2-encephalitis
Esser, D., Müller‐Miny, L., Heming, M., Paunovic, M., VanDuijn, M. M., Abrante, L., Mair, K. M., Strippel, C., Räuber, S. J., Dargvainiene, J., et al. (2025) · Brain · doi:10.1093/brain/awaf096 · Cited by 20
“28,29 To quantify, cells were scanned with the Vectra Polaris Automated Quantitative Pathology Imaging system from Perkin Elmer and quantified with Qupath software.”
Self-citationMix, M. R., van de Wall, S., Heidarian, M., Escue, E., Fain, C. E., Pewe, L. L., Hancox, L. S., Arumugam, S. A., Sievers, C. M., Badovinac, V. P., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115247 · Cited by 18
Immune checkpoint inhibition perturbs neuro-immune homeostasis and impairs cognitive function
Ifejeokwu, O. V., Do, A. H., El-Khatib, S. M., Ho, N., Zavala, A., Othy, S., & Acharya, M. M. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03442-3 · Cited by 23
“In addition to disrupting glial PD1 axis, PD1 blockade could unleash tissue resident memory T (T RM ) cells, which usually express high levels of PD1 [54–56], and these αPD1-unleashed T cells in turn dys-regulate neuro-immune homeostasis [33, 57].”
Tissue-resident immune cells in the pathogenesis of multiple sclerosis
Tian, J., Jiang, L., Chen, Z.-X., Yuan, Q., Liu, C., He, L., Jiang, F., & Rui, K. (2022) · Inflammation Research · doi:10.1007/s00011-022-01677-w · Cited by 18
“Autoreactive CD8+ TRM cells in the CNS exhibited proinflammatory and cytotoxic properties, presenting as key drivers of neuroinflammation and progressive loss of neurons [52].”
BackgroundChronic and delayed neurological manifestations of persistent infections
Pandya, D., & Johnson, T. P. (2023) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001154 · Cited by 20
Lymphocytes in autoimmune encephalitis: Pathogenesis and therapeutic target
Chen, J., Qin, M., Xiang, X., Guo, X., Nie, L., & Mao, L. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106632 · Cited by 19
Tissue‐resident memory T cells in diseases and therapeutic strategies
Xie, D., Lu, G., Mai, G., Guo, Q., & Xu, G. (2025) · MedComm · doi:10.1002/mco2.70053 · Cited by 21
Autoimmune-associated epilepsy – a challenging concept
Melzer, N., & Rosenow, F. (2024) · Seizure · doi:10.1016/j.seizure.2024.05.017 · Cited by 14
“These cells have been shown to drive compartmentalized parenchymal immune-inflammation in the brain [26,27].”
A year in review: brain barriers and brain fluids research in 2022
Keep, R. F., Jones, H. C., Hamilton, M. G., & Drewes, L. R. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00429-0 · Cited by 36
Mix, M. R., Kreitlow, B. L., Berton, R. R., Xu, J., Fain, C. E., van de Wall, S., Pewe, L. L., Hancox, L. S., Hassert, M., Kannan, S. K., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02174-y · Cited by 16
“T RM cells have been previously noted for their capacity to respond to pathogen-derived peptides in an antigen-dependent fashion 13,15,16,22,24 .”
T cells drive aging of the brain
Liston, A., & Yshii, L. (2023) · Nature Immunology · doi:10.1038/s41590-022-01390-0 · Cited by 15
de Fàbregues, O., Sellés, M. C., Ramos-Vicente, D., Roch, G., Vila, M., & Bové, J. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106308 · Cited by 12
“, 2018), others have reported that they are only important for their persistence (Frieser et al., 2022).”
Learning CNS immunopathology from therapeutic interventions
Schwab, N., & Wiendl, H. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adg7863 · Cited by 13
“This information might help in designing treatment strategies that either address this early infiltration or that specifically target immune cells residing within the parenchyma ( 45 – 48 ).”
BackgroundOligodendrocyte-derived IL-33 regulates self-reactive CD8+ T cells in CNS autoimmunity
Fonta, N., Pagé, N., Klimek, B., Piccinno, M., Liberto, G. D., Lemeille, S., Kreutzfeldt, M., Kastner, A. L., Ertuna, Y. I., Vincenti, I., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20241188 · Cited by 14
Self-citationLiberto, G. D., Égervári, K., Vogrig, A., Spatola, M., Piccinno, M., Vincenti, I., Wagner, I., Kreutzfeldt, M., Endmayr, V., Ostertag, K., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02882-7 · Cited by 14
Self-citationTargeted Therapy of Multiple Sclerosis: A Case for Antigen-Specific Tregs
Stauss, H. J., & Zhong, Y. (2024) · Cells · doi:10.3390/cells13100797 · Cited by 14
Mair, K. M., Guggenberger, V., de Juan, L. V., Köck, U., Lassmann, H., Liblau, R., Bien, C. G., & Bauer, J. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03477-5 · Cited by 10
“This reveals that these T RM can be present as effector cells and can be seen as essential drivers of human CNS autoimmunity, as illustrated in our CD8-mediated mouse models [19].”
Self-citationPerriot, S., Jones, S., Genolet, R., Mathias, A., Lindsay, H. A., Bobisse, S., Liberto, G. D., Canales, M., Queiroz, L., Sauvage, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63573-1 · Cited by 11
“Indeed, they should also prove and validate the importance of the identified clone through in vivo studies on animal models.”
Self-citationMa, X., Zuo, Y., Hu, X., Chen, S., Zhong, K., Xue, R., Gui, S., Liu, K., Li, S., Zhu, X., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14682 · Cited by 7
Freeman, S. A., Ayoub, I., Dauvilliers, Y. A., & Liblau, R. (2025) · Seminars in Immunology · doi:10.1016/j.smim.2025.101962 · Cited by 8
Self-citationCoulibaly, A. S. K., Nozeran, L., Thomann, C., Alis, M., Bassot, E., Hassan, A., Porte, R., Belloy, M., Blanchard, N., & Masson, F. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115861 · Cited by 7
Self-citationAbdelwahab, T., Stadler, D., Knöpper, K., Arampatzi, P., Saliba, A., Kastenmüller, W., Martini, R., & Groh, J. (2023) · iScience · doi:10.1016/j.isci.2023.106698 · Cited by 8
“Recent observations support a local contribution of CD8 TRM cells to chronic CNS autoimmunity.(44,45) In multiple sclerosis, active lesions Figure 7.”
BackgroundTissue-resident memory T cells in human kidney transplants have alloreactive potential
Hullegie-Peelen, D. M., Mora, H. T., Dieterich, M., Heidt, S., Bindels, E. M., Hoogduijn, M. J., Hesselink, D. A., & Baan, C. C. (2024) · American Journal of Transplantation · doi:10.1016/j.ajt.2024.02.030 · Cited by 6
Park, S. J. (2025) · Virology Journal · doi:10.1186/s12985-025-02866-9 · Cited by 8
Pathogenesis and immunopathology of paraneoplastic disorders
Quinot, V. A., & Höftberger, R. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-12-823912-4.00027-x · Cited by 5
Self-citationProteomic Profiling and Therapeutic Targeting of Oxidative Stress in Autoimmune Encephalitis
Zhang, F., Zhang, C., Sun, W., Xie, S., Wu, P., Zeng, G., & Liu, X. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02332-9 · Cited by 4
Tran, T.-T. T., Nguyen, T.-H. N., Dauvilliers, Y. A., Liblau, R., & Nguyen, X. (2024) · PLoS ONE · doi:10.1371/journal.pone.0297625 · Cited by 4
Self-citationMroz, N. M., Ciesielska, A., Ewing-Crystal, N. A., Dorman, L. C., Han, R. T., Barron, J. J., Silva, N. J., Magsig, A., Molofsky, A. V., Molofsky, A. B., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.28.630606 · Cited by 4
“Some of these cells co-expressed the TRM marker CD103 (Integrin α E ), which was previously identified on a subset of brain-resident T cells ( 19 , 20 , 22 , 23 , 29 ), and the brain TRM signature was distinct from circulating blood lymphocytes (fig.”
Pathogenic drivers of lupus myocarditis and potential therapeutic targets
Liu, Y., Murphy, K. M., Hung, Y. F., & Won, T. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01580-4 · Cited by 4
“Clinical studies have revealed the signi fi cance of CD8 + or CD4 + T RM cells in various autoimmune diseases, including Crohn ’ s disease, rheumatoid arthritis, encephalomyelitis and cutaneous lupus erythematosus 82 – 85 .”
Esser, D., Müller‐Miny, L., Heming, M., Paunovic, M., VanDuijn, M. M., Abrante, L., Mair, K., Strippel, C., Räuber, S. J., Bindels, E. M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.21.572754 · Cited by 4
Self-citationInflammatory Demyelinating Diseases of the Central Nervous System
Li, M., & Liu, Q. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-69188-1_8 · Cited by 4
Wang, L., Zhang, F., Wu, J., Yang, S., Zhou, D., Sun, X., Chang, B., Hu, B., & Zhou, Y. (2025) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70697 · Cited by 3
“CD8 + TRM-like cells, with 50% of them expressing CD103, were also detected in lesions of auto-immune encephalitis [66].”
PD‐1 Inhibits CD4+ TRM‐Mediated cDC1 Mobilization via Suppressing JAML in Human NSCLC
Shao, Z., Liu, Q., Xin, Z., Zhou, Z., Lin, M., Chen, D., Hao, Z., Chen, Y., Wu, W., Zhang, S., et al. (2026) · Advanced Science · doi:10.1002/advs.202507647 · Cited by 3
Chen, Y., Dang, J. L., Long, Q., Zang, N., Liu, L. M., Lu, Y., Zhao, W., Liang, R. Z., Yang, Y., Zhao, J., et al. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-026-01228-z · Cited by 2
“In addition, tissue resident CD8 + T cells are essential to drive chronic CNS autoimmunity and crucially dependent on CD4 + T cells [26].”
Kadel, S., Scheller, L., Leipold, A. M., Krammer, T., Raskó, T., Alb, M., Weis, P., Leberzammer, M., Schmitt, F., Stetter, C., et al. (2026) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-25-0278 · Cited by 3
Moon, J., Moutusy, S. I., Zhang, M., Ndayisaba, A., Rodriguez, D., Kodsi, D. N. E., Kuzkina, A., Younis, S., Jahanbani, S., van Dam, L. S., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2537271123 · Cited by 3
“Tissue - resident T cells are increasingly recognized as key effectors of tissue damage in both autoimmune and neurodegenerative diseases (27, 62, 63).”
Tan, Y., Liu, Q., Lu, J., Zhu, D., & Sun, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1687948 · Cited by 2
Saini, K., & Dhiman, P. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12128-8 · Cited by 2
“Chronic neuro logical and systemic disorders are linked to dysregulated inflammation and new research highlights the part T cells-microglia interactions play in CNS immune Modulation [ 62].”
Psychiatrische Autoimmunenzephalitis – Diagnose und therapeutische Ansätze
Hansen, N., Lüdecke, D., Maier, H. B., Steiner, J. H., & Neyazi, A. (2023) · PSYCH up2date · doi:10.1055/a-1400-8393 · Cited by 2
Pucciarelli, D. M., Lu, B. Y., Zlobec, I., & DiStasio, M. (2023) · GEN Biotechnology · doi:10.1089/genbio.2023.0030 · Cited by 2
Individualized therapy guided by single-cell sequencing in anti-GABAAR encephalitis
Shu, Y., Huang, Y., Li, Q., Li, H., Li, Z., Ye, J., Chen, J., Li, J., Fang, L., Li, J., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03300-y · Cited by 4
Immune cells impede repair of old neurons
Gaudenzio, N., & Liblau, R. (2022) · Science · doi:10.1126/science.abp9878 · Cited by 2
Self-citationLi, D., & Zhang, S. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad096 · Cited by 2
Corbin-Stein, N. J., Childers, G. M., Webster, J. M., Zane, A., Yang, Y., Ali, M. A., Sandoval, I. M., Manfredsson, F. P., Kordower, J. H., Tyrrell, D. J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.02.597035 · Cited by 3
Paraneoplastic neurological syndromes
Villagrán‐García, M., Farina, A., & Honnorat, J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00060-6 · Cited by 2
Nozuma, S., Dozono, M., Tanaka, M., Kodama, D., Yoshida, T., Higuchi, Y., Sakiyama, Y., Matsuura, E., Matsuzaki, T., Takashima, H., et al. (2025) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200508 · Cited by 1
Bei, L., Liao, J., Yang, Z., Li, S., Huang, M., & Lei, L. (2026) · Renal Failure · doi:10.1080/0886022x.2026.2624286 · Cited by 1
Living rent free in your head: resident memory T cells
Degefu, H. N., Kleist, S. A., & Rosato, P. C. (2026) · ImmunoHorizons · doi:10.1093/immhor/vlaf074 · Cited by 4
Xie, D., Tian, Y., Zhang, J., He, M., & Lu, L. W. A. G. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1014806 · Cited by 1
Korn, T. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-823848-6.00004-x · Cited by 1
White, P. J. (2009) · ProQuest LLC eBooks · Cited by 1
Porte, R., Belloy, M., Audibert, A., Bassot, E., Aïda, A., Alis, M., Miranda-Capet, R., Jourdes, A., van Gisbergen, K. P. J. M., Masson, F., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.08.579453 · Cited by 1
Self-citationPerriot, S., Jones, S., Genolet, R., Mathias, A., Lindsay, H. A., Bobisse, S., Liberto, G. D., Canales, M., Queiroz, L., Sauvage, C., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.25.586688 · Cited by 1
Self-citationWolf, D. M., Hotchkiss, K. M., Reesman, R. A., Pfaller, C. K., Moelker, E., Hoyt-Miggelbrink, A. M., Fain, C. E., Blethen, K. E., Norberg, P. K., Wallace, S. E., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.25.696510 · Cited by 2
Fonta, N., Pagé, N., Klimek, B., Piccinno, M., Liberto, G. D., Lemeille, S., Kreutzfeldt, M., Kastner, A. L., Ertuna, Y. I., Vincenti, I., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.09.602661
Self-citationOverview of Mechanisms Underlying Neuroimmune Diseases
Sonar, S. A., & Lal, G. (2024) · Springer eBooks · doi:10.1007/978-3-031-24297-7_1-1
Overview of Mechanisms Underlying Neuroimmune Diseases
Sonar, S. A., & Lal, G. (2024) · Springer eBooks · doi:10.1007/978-3-031-60006-7_1
Liblau, R. (2025) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2024.11.026
Self-citationWilke, J. B. H., Ntolkeras, A., Gastaldi, V. D., Borowski, K., Teegen, B., STÖCKER, W., Lühder, F., Nave, K., & Ehrenreich, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-08035-w
Recirculating and Resident Memory CD8+ T Cells
Gebhardt, T., Newland, L. G. M., & Bedoui, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00285-4
Lindbohm, J. V., Stražar, M., Lee, H.-M., Ashenberg, O., Mars, N., Sipilä, P. N., Ripatti, S., Graham, D. B., Kivimäki, M., & Xavier, R. J. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71282 · Cited by 1
Role of T-cell immunity in the pathophysiology of Alzheimer’s disease and other Tauopathies
Matta, K. (2024) · theses.fr (ABES) · doi:10.70675/cea4fe5ez67c3z4445z92f7z39af62ba059b
Wang, Z. X., Han, D., Qiao, X., Zhao, X., Zhao, C., Liu, S., Tao, R., Jin, M., & Qu, P. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1740656 · Cited by 1
Wu, D., Zhang, S., Jamal, Y. A., Sarkar, T. T., Tomczak, A. J., Sumera, J., Oak, J. S., Melamed, E., Nie, E. H., Galetta, K. M., et al. (2026) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlag050
Steffke, E. E., Latifi, L., Hana, T., Hara, A., Coombs, M., Spurgeon, J., McAuliffe, J., Almeida, V. P., Wicki, A., Malak, S. A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.18.733241
Wolf, D. M., Moelker, E., Wallace, S. E., Reesman, R. A., Hotchkiss, K. M., Blethen, K. E., Hemmers, S., Pfaller, C. K., Borchers, A. L., Norberg, P. K., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03968-z
Gui, R., Zhou, W., Deng, J., Shi, L., & Sun, G. (2026) · Environmental Health · doi:10.1186/s12940-026-01335-2
“…directly acting on the central nervous system [57], or exerting effects through pathways such as oxidative stress; (3) The neuroinflammatory response may have compartmental characteristics [58], and the association between its local activation and changes in systemic circulatory markers is limited.”
Tabatabaei, F., & Bromley, S. K. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1903750
Huang, A., Liu, Z., & Xu, W. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117389
Single‐Cell Profiling Reveals Clonally Expanded CX3CR1 + T Cells in Anti‐NMDA Receptor Encephalitis
Yan, L., Zhang, E., Ma, Y., Meng, Z., Li, S., Ren, Y., Tian, X., He, Y., Battaglia, G., Zhou, D., et al. (2026) · Advanced Science · doi:10.1002/advs.77608 · Cited by 1
Gallus, M., Khan, S. H., Zhao, A., Benway, H., Lu, J., Nejo, T., Watchmaker, P. B., & Okada, H. (2026) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-026-00944-8
Metadata
- Authors
- Frieser, D., Pignata, A., Khajavi, L., Shlesinger, D., Gonzalez-Fierro, C., Nguyen, X.-H., Yermanos, A., Merkler, D., Höftberger, R., Desestret, V., Mair, K. M., Bauer, J., Masson, F., & Liblau, R. S.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- ETH Zurich (CH)
- University of Geneva (CH)
- Medical University of Vienna (AT)
- Lyon 1 Université (FR)
- Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University of Toulouse, CNRS, INSERM, UPS, 31024 Toulouse, France.
- Corresponding author
- Liblau, Roland S.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2022-04-13
- Volume
- 14
- Issue
- 640
- Pages
- eabl6157-eabl6157
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W4224029197
- Cited by
- 102
- References
- 50
- Citations by year
- 2026: 21 · 2025: 25 · 2024: 26 · 2023: 18 · 2022: 11
- FWCI
- 7.63
- Type
- journal article
- Language
- en
- Open access
- green
- hal.science
- Licence
- other-oa
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion)
- HAL (submittedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Agence Nationale de la Recherche (ANR-18-RAR3-0003, ANR-18-RHUS-0012)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tissue-resident memory T cells, CD8+ T cells, central nervous system autoimmunity, autoimmune encephalitis, blood-brain barrier, neuroinflammation, neuronal loss, CD4+ T cell help, T cell heterogeneity, autoimmune disease therapy
- MeSH terms
- Animals, Autoimmune Diseases, Central Nervous System, Immunologic Memory, Neurons, CD8-Positive T-Lymphocytes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.